XIAOXIAO WANG
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family PASADENA, CA NPI 1346089141
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family CA ABBVIE INC. All categories
General Payments — all program years on this page
$1,360.69
- Category: General Payments
- Program years: PY2024
- Record count: 48
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,360.69 across 48 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,234.79 | 46 |
| Education | $125.90 | 2 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $161.48 | 3 |
| Incyte Corporation | $153.72 | 3 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $148.92 | 2 |
| Lilly USA, LLC | $141.29 | 8 |
| Acerta Pharma LLC | $131.44 | 6 |
| E.R. Squibb & Sons, L.L.C. | $102.26 | 5 |
| Merck Sharp & Dohme Corporation | $89.10 | 3 |
| ARRAY BIOPHARMA INC | $84.73 | 4 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $52.96 | 2 |
| Janssen Biotech, Inc. | $36.38 | 2 |
| Ipsen Biopharmaceuticals, Inc | $31.41 | 1 |
| BeiGene USA, Inc. | $31.28 | 1 |
| EMD Serono, Inc. | $28.93 | 1 |
| Celgene Corporation | $28.00 | 1 |
| Sumitomo Pharma America, Inc. | $25.65 | 1 |
| PharmaEssentia USA Corporation | $25.02 | 1 |
| Exelixis Inc. | $22.91 | 1 |
| Legend Biotech USA Inc. | $22.39 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $21.44 | 1 |
| Helsinn Therapeutics (U.S.), Inc. | $21.38 | 1 |
By program year
| Program year | Amount | Records |
|---|---|---|
| 2024 | $1,360.69 | 48 |
Records — PY2024 (48)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.